Downes, T. J., Guthrie, B. ., Moreno-Martos, D. ., & Morales, D. R. (2025). Health conditions in adults with atrial fibrillation compared with the general population: a population-based cross-sectional analysis. Heart. http://doi.org/10.1136/heartjnl-2024-324618
B. Guthrie
First name
B.
Last name
Guthrie
Mansi, E. T., Rentsch, C. T., Bourne, R. S., Jeffery, A. ., Guthrie, B. ., & Lone, N. I. (2025). Benzodiazepine and z-drug prescribing in critical care survivors and the risk of rehospitalisation or death due to falls/trauma and due to any cause: a retrospective matched cohort study using the UK Clinical Practice Research Datalink. Intensive Care Med, 51, 125–136. http://doi.org/10.1007/s00134-024-07762-4
Launders, N. ., Jackson, C. A., Hayes, J. F., John, A. ., Stewart, R. ., Iveson, M. H., … Osborn, D. P. J. (2025). Prevalence and patient characteristics associated with cardiovascular disease risk factor screening in UK primary care for people with severe mental illness: an electronic healthcare record study. BMJ Ment Health, 28. http://doi.org/10.1136/bmjment-2024-301409
Mansi, E. T., Rentsch, C. T., Bourne, R. S., Guthrie, B. ., & Lone, N. I. (2024). Patient Characteristics and Practice Variation Associated With New Community Prescription of Benzodiazepine and z-Drug Hypnotics After Critical Illness: A Retrospective Cohort Study Using the UK Clinical Practice Research Datalink. Pharmacoepidemiol Drug Saf, 33, e70056. http://doi.org/10.1002/pds.70056
Mok, P. L. H., Carr, M. J., Guthrie, B. ., Morales, D. R., Sheikh, A. ., Elliott, R. A., … Ashcroft, D. M. (2024). Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study. Bmj, 385, e076268. http://doi.org/10.1136/bmj-2023-076268
Guthrie, B. ., Rogers, G. ., Livingstone, S. ., Morales, D. R., Donnan, P. ., Davis, S. ., … Payne, K. . (2024). The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis. Health Soc Care Deliv Res, 12, 1–275. http://doi.org/10.3310/kltr7714
Livingstone, S. ., Morales, D. R., Fleuriot, J. ., Donnan, P. T., & Guthrie, B. . (2023). External validation of the QLifetime cardiovascular risk prediction tool: population cohort study. BMC Cardiovasc Disord, 23, 194. http://doi.org/10.1186/s12872-023-03209-8
Livingstone, S. J., Morales, D. R., McMinn, M. ., Eke, C. ., Donnan, P. ., & Guthrie, B. . (2022). Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population. BMJ Med, 1, e000316. http://doi.org/10.1136/bmjmed-2022-000316
Livingstone, S. J., Guthrie, B. ., McMinn, M. ., Eke, C. ., Donnan, P. T., & Morales, D. R. (2023). Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study. Lancet Healthy Longev, 4, e43-e53. http://doi.org/10.1016/s2666-7568(22)00290-2
Livingstone, S. J., Guthrie, B. ., Donnan, P. T., Thompson, A. ., & Morales, D. R. (2022). Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. BMC Med, 20, 152. http://doi.org/10.1186/s12916-022-02349-6